Neurofibrillary tangles and Alzheimer's disease
- PMID: 9748670
- DOI: 10.1159/000007969
Neurofibrillary tangles and Alzheimer's disease
Abstract
The neuropathological diagnosis of Alzheimer's disease relies on the presence of both neurofibrillary tangles and senile plaques. The number of neurofibrillary tangles is tightly linked to the degree of dementia, suggesting that the formation of neurofibrillary tangles more directly correlates with neuronal dysfunction. The regional pattern of areas affected by neurofibrillary tangles formation during the course of the disease is relatively stereotyped. Neurofibrillary tangles are composed of highly phosphorylated forms of the microtubule-associated protein tau. Phosphorylated tau proteins accumulate early in neurons, even before formation of neurofibrillary tangles, suggesting that an imbalance between the activities of protein kinases and phosphatases acting on tau is an early phenomenon. The latter might be related to changes in signalling through transduction cascades, since many of the protein kinases generating phosphorylated tau species participate in signalling pathways. The accumulation of neurofibrillary tangles and phosphorylated tau species is associated with disturbances of the microtubule network and, as a consequence of the latter, of axoplasmic flows. The mechanistic relationship between the formation of neurofibrillary tangles and senile plaques is still little understood and in vivo formation of neurofibrillary tangles in experimental models has not yet been achieved. Future animal models, e.g. transgenic animals expressing combined key human proteins, will hopefully reproduce faithfully all the major cellular lesions of the disease.
Similar articles
-
The role of neurofibrillary tangles in Alzheimer disease.Acta Neurol Belg. 1998 Jun;98(2):165-74. Acta Neurol Belg. 1998. PMID: 9686275 Review.
-
The pathology of the neuronal cytoskeleton in Alzheimer's disease.Biochim Biophys Acta. 1992 Nov 10;1160(1):134-42. doi: 10.1016/0167-4838(92)90047-h. Biochim Biophys Acta. 1992. PMID: 1384716
-
Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.Neurobiol Aging. 2017 Jul;55:202-212. doi: 10.1016/j.neurobiolaging.2017.03.031. Epub 2017 Apr 5. Neurobiol Aging. 2017. PMID: 28464981
-
Tau protein and the neurofibrillary pathology of Alzheimer's disease.Trends Neurosci. 1993 Nov;16(11):460-5. doi: 10.1016/0166-2236(93)90078-z. Trends Neurosci. 1993. PMID: 7507619 Review.
-
Neurofibrillary tangles and tau phosphorylation.Biochem Soc Symp. 2001;(67):81-8. doi: 10.1042/bss0670081. Biochem Soc Symp. 2001. PMID: 11447842
Cited by
-
Glucose metabolism and AD: evidence for a potential diabetes type 3.Alzheimers Res Ther. 2022 Apr 20;14(1):56. doi: 10.1186/s13195-022-00996-8. Alzheimers Res Ther. 2022. PMID: 35443732 Free PMC article. Review.
-
The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease.Future Sci OA. 2015 Nov 1;1(3):FSO11. doi: 10.4155/fso.15.9. eCollection 2015 Nov. Future Sci OA. 2015. PMID: 28031886 Free PMC article. Review.
-
Compensating for synaptic loss in Alzheimer's disease.J Comput Neurosci. 2014 Feb;36(1):19-37. doi: 10.1007/s10827-013-0462-8. Epub 2013 Jun 2. J Comput Neurosci. 2014. PMID: 23728490
-
In Vitro and In Vivo Neuroprotective Effects of Sarcosine.Biomed Res Int. 2022 Oct 15;2022:5467498. doi: 10.1155/2022/5467498. eCollection 2022. Biomed Res Int. 2022. PMID: 36281465 Free PMC article.
-
Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.Int J Mol Sci. 2020 Sep 10;21(18):6630. doi: 10.3390/ijms21186630. Int J Mol Sci. 2020. PMID: 32927795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical